C
Caribou Biosciences D
D
CRBU
1.30000
USD
-0.11
(-7.80%)
مغلق
حجم التداول
16,159
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
117,718,493
المقالات
العنوان: Caribou Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPRplatform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipelineof allogeneic CAR-T and CAR-NK cell therapies.